These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 132695)
1. Some studies of feprazone. Haslock I; Burkinshaw L; Berry DJ; Donovan B; Wright V Rheumatol Rehabil; 1976 May; 15(2):81-6. PubMed ID: 132695 [TBL] [Abstract][Full Text] [Related]
2. A trial of feprazone in ankylosing spondylitis. Harkness AJ; Burry HC; Grahame R Rheumatol Rehabil; 1977 Aug; 16(3):158-61. PubMed ID: 333540 [TBL] [Abstract][Full Text] [Related]
3. Feprazone compared with indomethacin in the management of rheumatoid arthritis. Sturrock R; Isaacs A; Hart FD Practitioner; 1975 Jul; 215(1285):94-7. PubMed ID: 1103113 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal blood loss on phenylbutazone and feprazone. Macfarlane JD; Maisey MN; Grahame R; Burry HC Rheumatol Rehabil; 1976 May; 15(2):108-11. PubMed ID: 132693 [TBL] [Abstract][Full Text] [Related]
5. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance. Fletcher MR; Loebl W; Scott JT Ann Rheum Dis; 1975 Apr; 34(2):190-4. PubMed ID: 1094965 [TBL] [Abstract][Full Text] [Related]
6. A monitored-release study of methrazone in general practice. Harris PG J Int Med Res; 1980; 8(4):276-82. PubMed ID: 6447635 [TBL] [Abstract][Full Text] [Related]
7. Double-blind trial of feprazone and phenylbutazone in acute gout. Reardon JA; Stockman A; Darlington LG; Scott JT Curr Med Res Opin; 1980; 6(7):445-8. PubMed ID: 6988172 [TBL] [Abstract][Full Text] [Related]
8. Miscellaneous rheumatological conditions treated in monitored-release studies with feprazone. Harris PG J Int Med Res; 1981; 9(4):248-52. PubMed ID: 6973494 [TBL] [Abstract][Full Text] [Related]
9. A double-blind trial of feprazone in osteoarthritis of the hip. Bain LS; Lynch MP; Bruce GM Curr Med Res Opin; 1977; 4(9):665-9. PubMed ID: 338255 [TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of feprazone in rheumatoid arthritis (author's transl)]. Shichikawa K; Maeda A; Iwasaki Y Ryumachi; 1979 Apr; 19(2):147-63. PubMed ID: 375431 [No Abstract] [Full Text] [Related]
12. Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone. Br Med J; 1978 Jun; 1(6125):1466-7. PubMed ID: 306273 [No Abstract] [Full Text] [Related]
13. Thrombocytopenia and haemolytic anaemia due to feprazone. Bell PM; Humphrey CA Br Med J (Clin Res Ed); 1982 Jan; 284(6308):17. PubMed ID: 6797620 [No Abstract] [Full Text] [Related]
14. [Results of an open study and a controlled comparative study of feprazone and naproxen in patients with rheumatoid arthritis or osteoarthrosis (author's transl)]. Crone M; Geimer R Wien Med Wochenschr; 1981 Dec; 131(23-24):597-601. PubMed ID: 7039147 [TBL] [Abstract][Full Text] [Related]
15. Fenbufen and indomethacin in the treatment of rheumatoid arthritis. A comparative double-blind, crossover study. Ammitzbøll F Scand J Rheumatol Suppl; 1979; (23):5-10. PubMed ID: 373083 [No Abstract] [Full Text] [Related]
16. Fixed drug eruptions with feprazone are linked to HLA-B22. Pellicano R; Lomuto M; Ciavarella G; Di Giorgio G; Gasparini P J Am Acad Dermatol; 1997 May; 36(5 Pt 1):782-4. PubMed ID: 9146544 [No Abstract] [Full Text] [Related]
17. The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis. Singer F; Gruber J; Graber J; Reinthaler M; Thumb N Arzneimittelforschung; 1982; 32(4):427-9. PubMed ID: 7201815 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of feprazone for long-term treatment of rheumatoid arthritis and osteoarthritis. Bianchi G; Cerri B; Grasso S; Carazzi R; Dotti F; Ongari R; Cerrato O; Viara M Clin Ther; 1981; 3(5):349-55. PubMed ID: 7471130 [TBL] [Abstract][Full Text] [Related]